BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 4814464)

  • 1. Maternal serum hormonal changes in hypertonic saline-induced abortion.
    Crystle CD; Hanson FW; Stevens VC
    Obstet Gynecol; 1974 Mar; 43(3):447-52. PubMed ID: 4814464
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of human chorionic somatomammotrophin (HCS) and human chorionic gonadotrophin (HCG) following intra-amniotic injection of hypertonic saline.
    Vaidya PR; Sheth AR; Rao SS; Thakur SS; Raikar
    J Obstet Gynaecol India; 1975 Oct; 25(5):619-26. PubMed ID: 1228028
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum human chorionic gonadotropin, human chorionic somatomammotropin, and progesterone following intra-amniotic injection of hypertonic urea.
    Raud HR; Balsdon MJ; Collins JA
    Am J Obstet Gynecol; 1972 Aug; 113(7):887-94. PubMed ID: 4635737
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of sulprostone on prolactin, HPL, HCG, progesterone and estradiol serum level in abortion induction in the first trimester in primigravidae].
    Rudolf K; Kunkel S; Rüting M; Drewelow B
    Zentralbl Gynakol; 1988; 110(13):827-31. PubMed ID: 3176736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prostaglandin F2 alpha and hypertonic saline on the placental function during midtrimester abortion.
    Jayaraman S; Sinha MK; Raghavan KS; Mathur VS; Rastogi GK; Devi PK
    Am J Obstet Gynecol; 1975 Feb; 121(4):528-30. PubMed ID: 1146879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L; Caldwell BV; Brock WA; Anderson GG; Hobbins JC
    J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone and enzyme assays in pregnancy. II. The human chorionic somatomammotrophin, progesterone and placental cystine-aminopeptidase levels in normal pregnancy.
    Christensen A; Froyshov D; Fylling P
    Acta Endocrinol (Copenh); 1974 May; 76(1):201-8. PubMed ID: 4406585
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the outcome of pregnancy in threatened abortion by biochemical methods.
    Karjalainen O; Stenman U; Wichmann K; Widholm O
    Ann Chir Gynaecol Fenn; 1974; 63(6):457-64. PubMed ID: 4140705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic significance of various hormonal parameters in pregnancies complicated by threatened abortion].
    Marsico S; Mancuso A; Oliva A; Pizzo A
    Minerva Ginecol; 1984; 36(7-8):381-9. PubMed ID: 6208512
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of gonadotrophin, oestrogens and progesterone by the primate placenta.
    Hobson BM
    Adv Reprod Physiol; 1971; 5():67-102. PubMed ID: 5005676
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis of placental insufficiency by radioimmunoassay of serum HCG and HPL].
    Spona J; Janisch H
    Wien Klin Wochenschr; 1972 Jun; 84(24):385-9. PubMed ID: 5042228
    [No Abstract]   [Full Text] [Related]  

  • 12. Value of HCS determinations in management of prolonged pregnancy.
    Hobbins JC; Goldstein L; Hofschild J
    Obstet Gynecol; 1974 Dec; 44(6):802-5. PubMed ID: 4215993
    [No Abstract]   [Full Text] [Related]  

  • 13. Human placental lactogen (HPL) levels in maternal serum during abortion induced by intra- and extra-amniotic injection of prostaglandin F2a.
    Ylikorkala O; Pennanen S
    J Obstet Gynaecol Br Commonw; 1973 Oct; 80(10):927-31. PubMed ID: 4757501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and surveillance of early pregnancy complications with the determination of plasma estrone, estradiol-17 beta, estriol, progesterone and HPL and with the graduated urinary pregnancy test (proceedings)].
    Strecker JR; Negulescu R; Dahlén H; Musch K
    Arch Gynakol; 1977 Jul; 224(1-4):88-9. PubMed ID: 579954
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma hormone changes during infusions of prostaglandins F2alpha and E2 for therapeutic abortion.
    Newton J; Collins W
    Adv Biosci; 1973; 9():689-99. PubMed ID: 4805881
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of human chorionic gonadotropin in recurrent abortion.
    Sandler SW; Baillie P
    S Afr Med J; 1979 May; 55(21):832-5. PubMed ID: 472911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal changes in patients undergoing therapeutic abortion with prostaglandin F2alpha, 15(S)-15-methyl-prostaglandin F2alpha and hypertonic saline.
    Laumas KR; Rahman SA; Hingorani V; Puri CP; Baliga N; Laumas V
    Contraception; 1974 Dec; 10(6):617-36. PubMed ID: 4448072
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma hormone profiles following high-dose intraamniotic prostaglandin F2alpha.
    Craft I; Carriere E; Youssefnejadian E
    Obstet Gynecol; 1974 Jul; 44(1):135-41. PubMed ID: 4834807
    [No Abstract]   [Full Text] [Related]  

  • 19. Mid-trimester abortion with intraamniotic saline and intravenous oxytocin.
    Ballard CA; Quilligan EJ
    Obstet Gynecol; 1973 Mar; 41(3):447-50. PubMed ID: 4688261
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocrinologic events in early pregnancy failure.
    Aspillaga MO; Whittaker PG; Grey CE; Lind T
    Am J Obstet Gynecol; 1983 Dec; 147(8):903-8. PubMed ID: 6650626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.